Fennec Pharmaceuticals

FENC

NASDAQHealth Care

Income Statement

Total Revenue$47.54M

Gross Profit$44.35M

Operating Income$2.57M

EBITDA$4M

EBIT$4M

Pre-tax Income$-9.64M

Net Income$-436K

Net Cash$30.72M

Cash Equivalent$40.3M

Total Debt$26.84M

Net Debt$-3.88M

Book Value$-2.35M

Net Cash Per Share0.90

Book Value Per Share-0.09

Return on Equity (ROE)-110.02%

Return on Assets (ROA)-97.00%

Return on Invested Capital (ROI)-83.53%

Net Profit Margin-92.00%

Current Ratio6.38

Quick Ratio5.78

Long-Term Debt / Equity0.32